Aldons J Lusis Selected Research

Fibrosis (Cirrhosis)

12/2021	Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice.
12/2021	NOTUM promotes thermogenic capacity and protects against diet-induced obesity in male mice.
1/2021	Liver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner.
1/2021	The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice.
10/2019	Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease.
12/2018	The Genetic Architecture of Diet-Induced Hepatic Fibrosis in Mice.
1/2016	Genetic Dissection of Cardiac Remodeling in an Isoproterenol-Induced Heart Failure Mouse Model.
2/2015	Mapping genetic contributions to cardiac pathology induced by Beta-adrenergic stimulation in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aldons J Lusis Research Topics

Disease

94	Atherosclerosis 03/2024 - 01/2002
38	Obesity 05/2024 - 05/2002
26	Inflammation (Inflammations) 09/2022 - 05/2002
25	Insulin Resistance 05/2024 - 06/2003
17	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 01/2002
16	Heart Failure 01/2024 - 07/2010
15	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 05/2002
13	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2021 - 01/2004
11	Non-alcoholic Fatty Liver Disease 01/2023 - 06/2015
11	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 02/2010 - 01/2002
10	Type 2 Diabetes Mellitus (MODY) 12/2023 - 04/2005
9	Atherosclerotic Plaque (Atheroma) 12/2021 - 07/2008
9	Hypertriglyceridemia 05/2013 - 01/2002
8	Fibrosis (Cirrhosis) 12/2021 - 02/2015
8	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2002
8	Hyperlipidemias (Hyperlipidemia) 01/2019 - 11/2002
7	Body Weight (Weight, Body) 12/2019 - 03/2006
6	Hypertrophy 12/2021 - 11/2014
6	Fatty Liver 01/2021 - 06/2004
5	Hyperglycemia 01/2021 - 05/2006
5	Hypercholesterolemia 01/2021 - 01/2002
5	Thrombosis (Thrombus) 01/2019 - 04/2002
5	Heart Diseases (Heart Disease) 10/2018 - 04/2011
4	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 10/2019
4	Cardiomegaly (Heart Hypertrophy) 01/2023 - 02/2015
4	Infections 01/2021 - 09/2004
4	Myocardial Infarction 03/2016 - 10/2008
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2019
3	Glucose Intolerance 01/2019 - 03/2009
3	Stroke (Strokes) 01/2017 - 05/2013
3	Coronary Disease (Coronary Heart Disease) 01/2013 - 04/2003
3	Vascular Calcification 08/2010 - 06/2002
2	Neoplasms (Cancer) 05/2024 - 02/2010
2	Liver Diseases (Liver Disease) 01/2023 - 01/2023
2	Hyperinsulinism (Hyperinsulinemia) 01/2023 - 06/2004
2	Alcoholic Fatty Liver 05/2022 - 10/2019
2	Heart Injuries 01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

41	LipidsIBA 03/2024 - 04/2002
30	CholesterolIBA 03/2024 - 01/2002
23	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 05/2002
23	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2002
21	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022 - 04/2011
18	Apolipoproteins E (ApoE)IBA 12/2023 - 04/2002
18	ApolipoproteinsIBA 12/2023 - 01/2002
16	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2004
15	Lipoproteins (Lipoprotein)IBA 01/2021 - 01/2002
14	Insulin (Novolin)FDA Link 02/2021 - 05/2002
13	LDL Receptors (LDL Receptor)IBA 01/2021 - 07/2002
10	Choline (Choline Chloride)IBA 01/2022 - 04/2011
9	oxidized low density lipoproteinIBA 03/2024 - 04/2002
9	EnzymesIBA 01/2022 - 04/2002
9	Aryldialkylphosphatase (Paraoxonase)IBA 10/2020 - 07/2002
8	Phospholipids (Phosphatides)FDA LinkGeneric 12/2018 - 06/2004
7	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2023 - 02/2015
7	Transcription Factors (Transcription Factor)IBA 09/2022 - 04/2004
7	trimethylamineIBA 01/2022 - 05/2013
6	CytokinesIBA 05/2022 - 08/2006
6	Fatty Acids (Saturated Fatty Acids)IBA 12/2018 - 06/2004
5	HDL CholesterolIBA 03/2024 - 03/2013
5	Antisense OligonucleotidesIBA 01/2023 - 01/2015
5	CollagenIBA 12/2021 - 11/2014
5	dimethylaniline monooxygenase (N-oxide forming) (flavin-containing monooxygenase)IBA 01/2019 - 01/2013
5	Messenger RNA (mRNA)IBA 01/2014 - 06/2004
5	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 10/2008 - 07/2002
4	Hormones (Hormone)IBA 01/2022 - 03/2009
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2018
4	LigandsIBA 12/2021 - 05/2002
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 04/2004
4	Adenosine Triphosphate (ATP)IBA 01/2019 - 08/2012
4	Apolipoproteins B (ApoB)IBA 02/2016 - 04/2002
4	ChromatinIBA 01/2016 - 08/2014
4	HDL LipoproteinsIBA 09/2013 - 01/2002
4	LDL CholesterolIBA 05/2008 - 04/2004
4	Apolipoprotein A-II (Apolipoprotein A2)IBA 04/2008 - 06/2003
3	AcidsIBA 01/2024 - 06/2004
3	Amino Acids FDA Link 12/2023 - 07/2012
3	FructoseIBA 01/2023 - 10/2020
3	Sucrose (Saccharose)IBA 01/2023 - 01/2013
3	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 10/2021 - 12/2006
3	Macrophage Colony-Stimulating FactorIBA 01/2021 - 02/2010
3	AntioxidantsIBA 01/2021 - 01/2011
3	Estrogen ReceptorsIBA 01/2020 - 02/2015
3	Particulate MatterIBA 12/2019 - 01/2007
3	Liver X ReceptorsIBA 01/2018 - 09/2002
3	Bile Acids and Salts (Bile Acids)IBA 04/2015 - 10/2004
3	Carnitine (L-Carnitine)FDA LinkGeneric 11/2014 - 05/2013
3	Peroxidase (Myeloperoxidase)IBA 09/2013 - 09/2004
3	Oxidants (Oxidizing Agents)IBA 09/2013 - 09/2004
3	Leptin ReceptorsIBA 01/2012 - 05/2002
3	ThioredoxinsIBA 10/2008 - 04/2004
3	Arachidonic Acid (Vitamin F)IBA 10/2008 - 01/2004
2	IronIBA 04/2024 - 12/2013
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2023 - 12/2018
2	ProteomeIBA 01/2023 - 01/2019
2	AcyltransferasesIBA 01/2023 - 10/2019
2	Uric Acid (Urate)IBA 01/2023 - 07/2010
2	Matrix Gla ProteinIBA 01/2023 - 08/2010
2	OxysterolsIBA 05/2022 - 06/2010

Therapy/Procedure

8	Therapeutics 01/2022 - 02/2010
5	Transplantation 01/2021 - 09/2002